
The objective of our study was to assess the zzso risk of and zzso factors for the development of clinically zzso multiple sclerosis zzso following zzso zzso In a prospective cohort study design, 388 patients, who did not have probable or zzso zzso at study entry enrolled in the zzso zzso Treatment Trial between 1988 and 1991, and were followed for the development of zzso The zzso cumulative probability of zzso was zzso and did not differ by treatment zzso zzso impairment in the patients who developed zzso was generally zzso Brain zzso performed at study entry was a strong predictor of zzso with the zzso risk of zzso ranging from zzso in the 202 patients with no zzso zzso to 51% in the 89 patients with three or more zzso zzso Independent of brain zzso the presence of prior zzso zzso symptoms was also zzso of the development of zzso Lack of pain, the presence of zzso disk zzso and mild visual acuity loss were features of the zzso zzso associated with a low risk of zzso among the 189 patients who had no brain zzso zzso and no history of zzso symptoms or zzso zzso in the fellow zzso The zzso risk of zzso following zzso zzso is highly dependent on the number of zzso present on brain zzso However, even a normal brain zzso does not zzso the development of zzso In these patients with no brain zzso zzso certain clinical features identify a zzso with a particularly low zzso risk of zzso 

